Literature DB >> 27861295

Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.

Kristopher P Croome1, David D Lee, Andrew P Keaveny, C Burcin Taner.   

Abstract

BACKGROUND: Published reports describing the national experience with liver grafts from donation after cardiac death (DCD) donors have resulted in reservations with their widespread utilization. The present study aimed to investigate if temporal improvements in outcomes have been observed on a national level and to determine if donor and recipient selection have been modified in a fashion consistent with published data on DCD use in liver transplantation (LT).
METHODS: Patients undergoing DCD LT between 2003 and 2014 were obtained from the United Network of Organ Sharing Standard Transplant Analysis and Research file and divided into 3 equal eras based on the date of DCD LT: era 1 (2003-2006), era 2 (2007-2010), and era 3 (2011-2014).
RESULTS: Improvement in graft survival was seen between era 1 and era 2 (P = 0.001) and between era 2 and era 3 (P < 0.001). Concurrently, an increase in the proportion of patients with hepatocellular carcinoma and a decrease in critically ill patients, retransplant recipients, donor age, warm ischemia time greater than 30 minutes and cold ischemic time also occurred over the same period. On multivariate analysis, significant predictors of graft survival included: recipient age, biologic MELD score, recipient on ventilator, recipient hepatitis C virus + serology, donor age and cold ischemic time. In addition, even after adjustment for all of the aforementioned variables, both era 2 (hazard ratio, 0.81; confidence interval, 0.69-0.94; P = 0.007), and era 3 (hazard ratio, 0.61; confidence interval, 0.5-0.73; P < 0.001) had a protective effect compared to era 1.
CONCLUSIONS: The national outcomes for DCD LT have improved over the last 12 years. This change was associated with modifications in both recipient and donor selection. Furthermore, an era effect was observed, even after adjustment for all recipient and donor variables on multivariate analysis.

Entities:  

Mesh:

Year:  2016        PMID: 27861295     DOI: 10.1097/TP.0000000000001483

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come.

Authors:  Omar Haque; Qing Yuan; Korkut Uygun; James F Markmann
Journal:  Clin Transplant       Date:  2021-01-21       Impact factor: 2.863

2.  Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.

Authors:  Kristopher P Croome; Amit K Mathur; David D Lee; Adyr A Moss; Charles B Rosen; Julie K Heimbach; C Burcin Taner
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

3.  Current practice of normothermic regional perfusion and machine perfusion in donation after circulatory death liver transplants in Italy.

Authors:  Riccardo De Carlis; Andrea Lauterio; Leonardo Centonze; Vincenzo Buscemi; Andrea Schlegel; Paolo Muiesan; Luciano De Carlis
Journal:  Updates Surg       Date:  2022-02-28

4.  Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.

Authors:  Stephanie Ohara; Elizabeth Macdonough; Lena Egbert; Abigail Brooks; Blanca Lizaola-Mayo; Amit K Mathur; Bashar Aqel; Kunam S Reddy; Caroline C Jadlowiec
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

Review 5.  The Changing Landscapes in DCD Liver Transplantation.

Authors:  Kristopher P Croome; C Burcin Taner
Journal:  Curr Transplant Rep       Date:  2020-07-13

6.  Microsteatosis in Livers From Donation After Circulatory Death Donors Is Associated With Inferior Outcomes Following Liver Transplantation.

Authors:  Natalie M Bath; Glen Leverson; David P Al-Adra; Anthony M D'Alessandro; Joshua D Mezrich; David P Foley
Journal:  Liver Transpl       Date:  2020-09       Impact factor: 5.799

7.  The volume-outcomes relationship in donation after circulatory death liver transplantation.

Authors:  Aaron M Delman; Kevin M Turner; Allison M Ammann; Emily Schepers; Dennis M Vaysburg; Alex R Cortez; Robert M Van Haren; Greg C Wilson; Shimul A Shah; Ralph C Quillin
Journal:  Clin Transplant       Date:  2022-04-25       Impact factor: 3.456

Review 8.  Viability Assessment in Liver Transplantation-What Is the Impact of Dynamic Organ Preservation?

Authors:  Rebecca Panconesi; Mauricio Flores Carvalho; Matteo Mueller; David Meierhofer; Philipp Dutkowski; Paolo Muiesan; Andrea Schlegel
Journal:  Biomedicines       Date:  2021-02-07

9.  Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury.

Authors:  Omar Haque; Siavash Raigani; Ivy Rosales; Cailah Carroll; Taylor M Coe; Sofia Baptista; Heidi Yeh; Korkut Uygun; Francis L Delmonico; James F Markmann
Journal:  Front Surg       Date:  2021-06-17

10.  Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation.

Authors:  Anisa Nutu; Iago Justo; Alberto Marcacuzco; Óscar Caso; Alejandro Manrique; Jorge Calvo; Álvaro García-Sesma; María García-Conde; María Santos Gallego; Carlos Jiménez-Romero
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.